Skip to main content
Caplight Logo









Ascertain

Ascertain

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.ascertain.com/

Last Round

Series A

Apr 22, 2025

Total Funding Raised

$110M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ascertain is a healthcare technology company that provides an AI-powered automation platform to help health systems, payers, and provider groups streamline administrative operations.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

venture studiohealthcare AIagentic AIAI agentadministrative automationprior authorizationclinical AIcare coordinationhuman-in-the-loophealth techAI startup studiodenials managementeligibility verificationtech-enabled servicesSaaSAI agent security

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ascertain Comparables

Compare Ascertain with similar companies based on industry and business-model similarity.

Ascertain comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Healthcare Foundry
79%
BigRio
77%
Terrarium
77%

Ascertain Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 22, 2025
SeedApr 12, 2022

Key People

Founding team and executive leadership

Mark Michalski

Chief Executive Officer

Executive Team

Chris Mitchell

Chief Operating Officer

Executive Team

Eli Bernstein

Chief Product Officer

Executive Team

Molly O'Neill

Chief Commercial Officer

Executive Team

Ascertain Investors

Notable investors and investment history

Ascertain investors
InvestorRounds
Deerfield ManagementSeries A
Aegis VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2026

    Grew 33% QoQ from 45 to 60 employees.

  • Jun 18, 2026

    Monthly visitors increased 30% MoM, reaching 11.5K.

Ascertain Filings

Explore SEC and related filing metadata, where available.

Ascertain filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ascertain's valuation, stock price, and market status.

Is Ascertain a public or private company?

Ascertain is a private company.

What is the current stock price of Ascertain?

Ascertain is a private company with no public stock price. No recent secondary market data is available.

How much is Ascertain worth (valuation)?

Valuation information for Ascertain is not publicly available.

Can I buy Ascertain stock?

Ascertain shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ascertain's last funding round?

Ascertain's most recent funding round was Series A on April 22, 2025.

Who are the main investors in Ascertain?

Key investors in Ascertain include Deerfield Management.

Will Ascertain IPO soon?

No public IPO plans have been announced for Ascertain.

How can I track Ascertain secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ascertain's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range42
Year Founded2022
Last FundingApr 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?